The Cost-effectiveness of Screening for Type 2 Diabetes CDC Diabetes Cost-Effectiveness Study Group

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Economics

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-Effectiveness in Health and Medicine

  2016cited by this paper
• Screening for hypertension

  2007cited by this paper
• Foot Infections in diabetic patients

  2004cited by this paper
• Competing Practice Guidelines: Using Cost-Effectiveness Analysis To Make Optimal Decisions

  1998cited by this paper
• Does Hyperglycemia Really Cause Coronary Heart Disease?

  1997cited by this paper
• Working together to reduce poverty's damage

  1997cited by this paper
• Model of Complications of NIDDM: I. Model construction and assumptions

  1997cited by this paper
• Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

  1997cited by this paper
• Glycemia and Cardiovascular Risk

  1997cited by this paper
• A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels.

  1996cited by this paper
• The Onset of NIDDM and its Relationship to Clinical Diagnosis in Egyptian Adults

  1996cited by this paper
• Incidence and Determinants of Elevated Urinary Albumin Excretion in Pima Indians With NIDDM

  1995cited by this paper
• Screening for NIDDM in Nonpregnant Adults: A review of principles, screening tests, and recommendations

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• Lower limb amputation and the diabetic foot.

  1995cited by this paper
• Prevention and Treatment of the Complications of Diabetes Mellitus

  1995cited by this paper
• A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

  1995cited by this paper
• The Effect of Intensive Treatment of Diabetes Mellitus

  1994cited by this paper
• The contribution of non-insulin-dependent diabetes to lower-extremity amputation in the community.

  1994cited by this paper
• Screening for NIDDM: Why is there no national program?

  1994cited by this paper
• Screening for NIDDM: Opportunities for detection, treatment, and prevention

  1994cited by this paper
• Preventive Eye Care in People With Diabetes Is Cost-Saving to the Federal Government: Implications for health-care reform

  1994cited by this paper
• The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort

  1993cited by this paper
• Undiagnosed NIDDM: Clinical and Public Health Issues

  1993cited by this paper
• Prevalence of Microalbuminuria in Older-Onset Diabetes

  1993cited by this paper
• Association of HbA1c With Prevalent Cardiovascular Disease in the Original Cohort of the Framingham Heart Study

  1992cited by this paper
• Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis

  1992cited by this paper
• Diabetes mellitus in Egypt.

  1992cited by this paper
• Cost-effectiveness of breast cancer screening

  1992cited by this paper
• Cardiovascular disease risk profiles.

  1991cited by this paper
• Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.

  1989cited by this paper
• Epidemiology of Persistent Proteinuria in Type II Diabetes Mellitus: Population-Based Study in Rochester, Minnesota

  1988cited by this paper
• Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr

  1987cited by this paper
• The prevention of carcinoma of the cervix.

  1976cited by this paper
• [Therapy for diabetes].

  1966cited by this paper

• An Investigation of the Association between Health Screening and Dental Scaling in Korea

  2021cites this paper
• Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data

  2017cites this paper
• Prevention and Screening for Type 2 Diabetes Newfoundland and Labrador

  2016cites this paper
• Long-Term Effect of Population Screening for Diabetes on Cardiovascular Morbidity, Self-Rated Health, and Health Behavior

  2015cites this paper
• How Do Diabetes Models Measure Up? A Review of Diabetes Economic Models and ADA Guidelines

  2015cites this paper
• Predictors of hyperglycaemic individuals who do not follow up with physicians after screening in Japan: a cohort study.

  2014cites this paper